NOVARTIS AG CHF0.49 (REGD)NOVARTIS AG CHF0.49 (REGD)NOVARTIS AG CHF0.49 (REGD)

NOVARTIS AG CHF0.49 (REGD)

No trades
See on Supercharts
Next report date
Report period
Q2 2024
EPS estimate
1.67CHF
Revenue estimate
‪11.20 B‬CHF
Market capitalization
‪177.27 B‬CHF
‪13.34 B‬CHF
‪40.83 B‬CHF
‪1.75 B‬
Beta (1Y)
0.67

About NOVARTIS N

CEO
Vasant Narasimhan
Headquarters
Basel
Employees (FY)
‪76.06 K‬
Founded
1996
ISIN
CH0012005267
FIGI
BBG00LPCB5S5
Novartis AG is a holding company, which engages in the business of developing, manufacturing, and marketing healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment includes researching, distributing and selling patented pharmaceuticals. The Sandoz segment focuses on marketing finished dosage form medicines and intermediary products including active pharmaceutical ingredients. The Corporate segment is involved in group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 0QLR is 90.00 CHF — it has decreased by 0.55% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on LSIN exchange NOVARTIS AG CHF0.49 (REGD) stocks are traded under the ticker 0QLR.
NOVARTIS AG CHF0.49 (REGD) is going to release the next earnings report on Jul 18, 2024. Keep track of upcoming events with our Earnings Calendar.
0QLR stock is 1.57% volatile and has beta coefficient of 0.67. Check out the list of the most volatile stocks — is NOVARTIS AG CHF0.49 (REGD) there?
0QLR earnings for the last quarter are 1.29 CHF per share, whereas the estimation was 1.39 CHF resulting in a −7.31% surprise. The estimated earnings for the next quarter are 1.51 CHF per share. See more details about NOVARTIS AG CHF0.49 (REGD) earnings.
NOVARTIS AG CHF0.49 (REGD) revenue for the last quarter amounts to ‪9.62 B‬ CHF despite the estimated figure of ‪10.01 B‬ CHF. In the next quarter revenue is expected to reach ‪10.32 B‬ CHF.
Yes, you can track NOVARTIS AG CHF0.49 (REGD) financials in yearly and quarterly reports right on TradingView.
0QLR stock has risen by 7.41% compared to the previous week, the month change is a 4.17% rise, over the last year NOVARTIS AG CHF0.49 (REGD) has showed a 1.95% decrease.
0QLR net income for the last quarter is ‪2.35 B‬ CHF, while the quarter before that showed ‪7.52 B‬ CHF of net income which accounts for −68.76% change. Track more NOVARTIS AG CHF0.49 (REGD) financial stats to get the full picture.
Today NOVARTIS AG CHF0.49 (REGD) has the market capitalization of ‪175.11 B‬, it has increased by 2.78% over the last week.
Yes, 0QLR dividends are paid annually. The last dividend per share was 3.30 CHF. As of today, Dividend Yield (TTM)% is 3.69%. Tracking NOVARTIS AG CHF0.49 (REGD) dividends might help you take more informed decisions.
NOVARTIS AG CHF0.49 (REGD) dividend yield was 3.89% in 2023, and payout ratio reached 51.36%. The year before the numbers were 3.83% and 105.08% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, 0QLR shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NOVARTIS AG CHF0.49 (REGD) stock right from TradingView charts — choose your broker and connect to your account.
0QLR reached its all-time high on Jul 20, 2015 with the price of 103.11 CHF, and its all-time low was 1.00 CHF and was reached on Sep 21, 2018.
See other stocks reaching their highest and lowest prices.
As of Apr 28, 2024, the company has ‪76.06 K‬ employees. See our rating of the largest employees — is NOVARTIS AG CHF0.49 (REGD) on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So NOVARTIS AG CHF0.49 (REGD) technincal analysis shows the buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating NOVARTIS AG CHF0.49 (REGD) stock shows the strong buy signal. See more of NOVARTIS AG CHF0.49 (REGD) technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on NOVARTIS AG CHF0.49 (REGD) future price: according to them, 0QLR price has a max estimate of 119.71 CHF and a min estimate of 74.41 CHF. Read a more detailed NOVARTIS AG CHF0.49 (REGD) forecast: see what analysts think of NOVARTIS AG CHF0.49 (REGD) and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. NOVARTIS AG CHF0.49 (REGD) EBITDA is ‪18.76 B‬ CHF, and current EBITDA margin is 44.33%. See more stats in NOVARTIS AG CHF0.49 (REGD) financial statements.